CRL
Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang +7.1% ·
aliran saham +9.1% ·
posisi baru bersih +6.7%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 140 | -1 | 45.53M | $10.31B | +6 | −6 |
| Q1 2026 | 143 | -7 | 45.52M | $7.86B | +6 | −14 |
| Q4 2025 | 150 | +3 | 43.69M | $8.72B | +4 | — |
| Q3 2025 | 22 | 0 | 23.18M | $3.62B | +1 | −2 |
| Q2 2025 | 20 | +2 | 21.36M | $3.24B | +4 | −2 |
| Q1 2025 | 15 | 0 | 9.57M | $1.44B | +1 | −1 |
| Q4 2024 | 15 | +1 | 9.65M | $1.78B | +1 | — |
| Q3 2024 | 13 | -1 | 6.67M | $1.31B | — | −1 |
| Q2 2024 | 14 | — | 3.92M | $810.09M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.08M | +9.0% | $752.51M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (pasif) | 2.18M | — | $402.66M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasif) | 1.23M | +1.2% | $227.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasif) | 1.23M | +1.2% | $227.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Norges Bank ✦ (pasif) | 535.68K | +1.8% | $98.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Millennium Management ✦ | 372.22K | +1952.2% | $68.71M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 272.98K | -0.2% | $50.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 232.32K | +25.8% | $42.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 171.22K | -1.0% | $31.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 171.22K | -1.0% | $31.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 170.63K | +1101.8% | $31.50M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 170.63K | +1101.8% | $31.50M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 123.69K | +59.9% | $22.83M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 84.66K | Baru | $15.63M | 0.0% | New | 1 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 78.86K | +309.6% | $14.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 75.41K | +9.9% | $13.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 75.41K | +9.9% | $13.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 75.41K | +9.9% | $13.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Marshall Wace ✦ | 21.61K | -93.0% | $3.99M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 21.61K | -93.0% | $3.99M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Marshall Wace ✦ | 21.61K | -93.0% | $3.99M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 20.98K | -53.0% | $3.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 20.98K | -53.0% | $3.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 20.98K | -53.0% | $3.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| D. E. Shaw & Co. | $15.63M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 555 pemegang, 56.84M saham, $9.32B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.04K lbr · $599,711
Director · 573 lbr · $163,443
Officer · 3.71K lbr · $1.04M
Officer, Director · 6.50K lbr · $1.82M
Director · 28.73K lbr · $7.90M
Officer · 404 lbr · $104,446
Officer · 1.21K lbr · $311,529
Officer · 736 lbr · $190,278
Officer · 4.18K lbr · $1.08M
Officer · 1.27K lbr · $330,055
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi